TwinBeech Capital’s BeOne Medicines Ltd ONC Stock Holding History

TwinBeech Capital’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,347	Closed	-$1.15M	–	904
2023 Q1	$1.15M	Buy	+5,347	New	+$1.28M	0.02%	438
2022 Q4	–	Sell	-8,791	Closed	-$1.19M	–	980
2022 Q3	$1.19M	Buy	+8,791	New	+$1.51M	0.03%	426
2020 Q1	–	Sell	-1,793	Closed	-$297K	–	507
2019 Q4	$297K	Buy	+1,793	New	+$298K	0.09%	300

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

TwinBeech Capital's ONC Position: Q2 2023 in Review

TwinBeech Capital sold out of BeOne Medicines Ltd (ONC) in Q2 2023, closing a stake of 5,347 shares — an estimated $1.15M sold.

TwinBeech Capital first reported a position in ONC in Q4 2019 and held it in 3 quarters. The position peaked at $1.19M in Q3 2022. 208 funds tracked by Wall St. Rank hold ONC as of Q2 2023.

TwinBeech Capital reported no remaining BeOne Medicines Ltd position as of Q2 2023 after selling out during the quarter.
TwinBeech Capital sold 5,347 BeOne Medicines Ltd shares in Q2 2023, an estimated $1.15M.
TwinBeech Capital first reported a position in BeOne Medicines Ltd in Q4 2019 and held it in 3 quarters.
TwinBeech Capital's BeOne Medicines Ltd position peaked at $1.19M in Q3 2022.
208 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2023.

Based on TwinBeech Capital's 13F filing for Q2 2023, filed 14 Aug 2023.